A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

Elisabeth I. Heath, Melvin Gaskins, Henry C. Pitot, Roberto Pili, Winston Tan, Robert Marschke, Glenn Liu, David Hillman, Fazlul Sarkar, Shijie Sheng, Charles Erlichman, Percy Ivy

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer'. Together they form a unique fingerprint.